Association of cardiovascular-kidney-metabolic syndrome with postoperative major adverse cardiovascular and cerebrovascular events after non-cardiac surgery
The Cardiovascular-Kidney-Metabolic (CKM) syndrome is highly prevalent among Chinese adults (over 80%), yet its specific association with postoperative outcomes in patients undergoing non-cardiac surgery has not been fully elucidated. This study aimed to evaluate the association between CKM stages and the risk of 30-day major adverse cardiac and cerebrovascular events (MACCE) after non-cardiac surgery, and to identify the specific stage at which risk increases significantly. This single-center retrospective cohort study was conducted at the Second Affiliated Hospital of Army Medical University in Chongqing, China, including 178,232 adult patients aged 18 to 79 years who underwent non-cardiac surgery between July 1, 2016, and June 30, 2025. CKM Stages 0–4 were defined according to the 2023 American Heart Association scientific statement. The primary outcome was 30-day postoperative MACCE, a composite of all-cause mortality, non-fatal myocardial infarction, stroke, major arrhythmia, angina, pulmonary embolism, heart failure, or cardiac arrest. Multivariable logistic regression was used to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Among the 178,232 patients (median age, 52 years; 55.3% female), 88.8% were at CKM Stage ≥ 1. The overall incidence of postoperative MACCE was 4.3%, which increased stepwise across CKM stages from 1.5% in Stage 0 to 15.9% in Stage 4. After full adjustment for demographics, surgical factors, and comorbidities, the aORs (95% CIs) for MACCE compared with Stage 0 were 1.11 (0.96–1.30, P > 0.05) for Stage 1, 1.41 (1.25–1.60, P < 0.001) for Stage 2, 2.19 (1.90–2.53, P < 0.001) for Stage 3, and 2.91 (2.55–3.34, P < 0.001) for Stage 4. Subgroup analysis showed that men had a higher MACCE risk than women at Stages 0–2, but no significant sex difference was observed at Stages 3–4 (interaction P = 0.68 for Stage 3; P = 0.23 for Stage 4). Sensitivity analyses yielded consistent results. Higher CKM stages were independently associated with a stepwise increase in the risk of 30-day postoperative MACCE, with the risk becoming statistically significant at Stage 2. Whether this association should be used to guide perioperative management requires confirmation in prospective studies. While men exhibited a higher risk than women in Stages 0–2, the risk was similar between sexes in CKM Stages 3–4. Question. What is the association between Cardiovascular-Kidney-Metabolic syndrome stages and the risk of major adverse cardiovascular and cerebrovascular events (MACCE) after non-cardiac surgery? Findings. In this retrospective cohort study of 178,232 Chinese patients, higher CKM stage was an independent, graded risk factor for postoperative MACCE, and Stage 2 was the earliest stage associated with a statistically significant increase in postoperative MACCE risk. Men had a higher risk than women at stages 0–2, a difference that was not observed at stages 3–4. Meaning The findings support considering CKM stages into preoperative risk assessment to inform patient stratification and perioperative management.
Authors
- Hao Gui-qiang
- Hong Li (ORCID: https://orcid.org/0009-0009-0493-623X)
- Yi-Kai Liu
- Wan-Qiu Fan
- Jun-Yan Lai
- Chun-Yu Yu
- Fu-Hai Bai
Institutions
- Army Medical University (CN)
- UNSW Sydney (AU)
Publication Details
- Journal
- Journal of Anesthesia Analgesia and Critical Care
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1186/s44158-026-00474-9
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00